-
1
-
-
0023684531
-
Phase 1 trial of intravenously administered recombinant tumor necrosis factor-alpha in cancer patients
-
1. Feinberg, B., Kurzurock, R., Talpaz, M., Blick, M., Saks, S., and Gutterman, J. U. Phase 1 trial of intravenously administered recombinant tumor necrosis factor-alpha in cancer patients, J. Clin. Oncol. 6, 1328-1332 (1992).
-
(1992)
J. Clin. Oncol.
, vol.6
, pp. 1328-1332
-
-
Feinberg, B.1
Kurzurock, R.2
Talpaz, M.3
Blick, M.4
Saks, S.5
Gutterman, J.U.6
-
2
-
-
0026813323
-
The immunotherapy and gene therapy of cancer
-
2. Rosenberg, S. A. The immunotherapy and gene therapy of cancer, J. Clin. Oncol. 10, 180-199 (1992).
-
(1992)
J. Clin. Oncol.
, vol.10
, pp. 180-199
-
-
Rosenberg, S.A.1
-
5
-
-
0026556005
-
Hierarchy of sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs, and toxins
-
5. Safrit, J., Tsuchitani, T., Zighelboim, J., and Bonavida, B. Hierarchy of sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs, and toxins, Cancer Immunol. Immunother. 34, 321-328 (1992).
-
(1992)
Cancer Immunol. Immunother.
, vol.34
, pp. 321-328
-
-
Safrit, J.1
Tsuchitani, T.2
Zighelboim, J.3
Bonavida, B.4
-
6
-
-
0027232299
-
Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-fas antibody and drugs or toxins
-
6. Morimoto, H., Yonehara, S., and Bonavida, B. Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins, Cancer Res. 53, 2591-2596 (1993).
-
(1993)
Cancer Res.
, vol.53
, pp. 2591-2596
-
-
Morimoto, H.1
Yonehara, S.2
Bonavida, B.3
-
7
-
-
0024390026
-
Augmentation of antitumor efficacy by the combination of tumor necrosis factor and chemotherapeutic agents in vivo
-
7. Krosnick, J. A., Mule, J. J., McIntosh, J. K., and Rosenberg, S. A. Augmentation of antitumor efficacy by the combination of tumor necrosis factor and chemotherapeutic agents in vivo, Cancer Res. 49, 3729-3733 (1989).
-
(1989)
Cancer Res.
, vol.49
, pp. 3729-3733
-
-
Krosnick, J.A.1
Mule, J.J.2
McIntosh, J.K.3
Rosenberg, S.A.4
-
8
-
-
0027236106
-
Overcoming cis-diamminedichloroplatinum II resistance of human ovarian tumor cells by combination treatment with cis-diamminedichloroplatinum II and TNF-α
-
8. Mizutani, Y., and Bonavida, B. Overcoming cis-diamminedichloroplatinum II resistance of human ovarian tumor cells by combination treatment with cis-diamminedichloroplatinum II and TNF-α, Cancer 72, 809-818 (1993).
-
(1993)
Cancer
, vol.72
, pp. 809-818
-
-
Mizutani, Y.1
Bonavida, B.2
-
9
-
-
0027209190
-
Overcoming TNF-α and CDDP resistance of a human ovarian cancer cell line (C30) by treatment with buthionine sulfoximine in combination with TNF-α and/or CDDP
-
9. Mizutani, Y., and Bonavida, B. Overcoming TNF-α and CDDP resistance of a human ovarian cancer cell line (C30) by treatment with buthionine sulfoximine in combination with TNF-α and/or CDDP, Int. J. Oncol. 3, 229-235 (1993).
-
(1993)
Int. J. Oncol.
, vol.3
, pp. 229-235
-
-
Mizutani, Y.1
Bonavida, B.2
-
10
-
-
0030021993
-
Role of free radicals in the synergy achieved by treatment with both TNF-α and CDDP on human ovarian carcinoma cells
-
10. Uslu, R., and Bonavida, B. Role of free radicals in the synergy achieved by treatment with both TNF-α and CDDP on human ovarian carcinoma cells, Cancer 77, 725-732 (1996).
-
(1996)
Cancer
, vol.77
, pp. 725-732
-
-
Uslu, R.1
Bonavida, B.2
-
11
-
-
0006751498
-
Immunosupressive agents
-
(A. C. Sartorelli and D. G. Johns, Eds.), Springer-Verlag, New York
-
11. Hersh, E. M. Immunosupressive agents, in Antineoplastic and immunosupressive agents I (A. C. Sartorelli and D. G. Johns, Eds.), Springer-Verlag, New York, pp. 557-617 (1974).
-
(1974)
Antineoplastic and Immunosupressive Agents I
, pp. 557-617
-
-
Hersh, E.M.1
-
12
-
-
0011876855
-
Immunoregulation by cancer chemotherapeutic agents
-
(J. W. Hadder and A. Szentivanyi, Eds.), Plenum, New York
-
12. Ehrke, M. J., and Mihich, E. Immunoregulation by cancer chemotherapeutic agents, in The reticuloendothelial system: A comprehensive treatise (J. W. Hadder and A. Szentivanyi, Eds.), Plenum, New York, pp. 309-347 (1985).
-
(1985)
The Reticuloendothelial System: A Comprehensive Treatise
, pp. 309-347
-
-
Ehrke, M.J.1
Mihich, E.2
-
13
-
-
0018070027
-
Effect of chemotherapeutic agents on natural cell-mediated cytotoxicity in mice
-
13. Montavani, A., Luini, W., Vecchi, A., and Spreafico, F. Effect of chemotherapeutic agents on natural cell-mediated cytotoxicity in mice, J. Natl. Cancer Inst. 61, 1255-1258 (1978).
-
(1978)
J. Natl. Cancer Inst.
, vol.61
, pp. 1255-1258
-
-
Montavani, A.1
Luini, W.2
Vecchi, A.3
Spreafico, F.4
-
14
-
-
0020446174
-
Augmentation of the human immune response by cyclophosphamide
-
14. Berd, D., Mastrangelo, M., Engstrom, P., Paul, A., and Maguire, H. Augmentation of the human immune response by cyclophosphamide, Cancer Res. 42, 4862-4867 (1982).
-
(1982)
Cancer Res.
, vol.42
, pp. 4862-4867
-
-
Berd, D.1
Mastrangelo, M.2
Engstrom, P.3
Paul, A.4
Maguire, H.5
-
15
-
-
0014691619
-
Platinum compounds: A new class of potent antitumor agents
-
15. Rosenberg, B., Van Camp, L., Trosko, J. E., and Mansour, V. H. Platinum compounds: A new class of potent antitumor agents, Nature 222, 285-286 (1969).
-
(1969)
Nature
, vol.222
, pp. 285-286
-
-
Rosenberg, B.1
Van Camp, L.2
Trosko, J.E.3
Mansour, V.H.4
-
16
-
-
0021435857
-
Drugs five years later. Cisplatin
-
16. Loehrer, P. J., and Einhorn, L. H. Drugs five years later. Cisplatin, Ann. Intern. Med. 100, 704-713 (1984).
-
(1984)
Ann. Intern. Med.
, vol.100
, pp. 704-713
-
-
Loehrer, P.J.1
Einhorn, L.H.2
-
17
-
-
0016373567
-
Interaction between mammalian cell DNA and inorganic platinum compounds I. DNA interstrand cross-linking and cytotoxic properties of platinum II compounds
-
17. Pascoe, J. M., and Roberts, J. J. Interaction between mammalian cell DNA and inorganic platinum compounds I. DNA interstrand cross-linking and cytotoxic properties of platinum II compounds, Biochem. Pharmacol. 23, 1345-1357 (1974).
-
(1974)
Biochem. Pharmacol.
, vol.23
, pp. 1345-1357
-
-
Pascoe, J.M.1
Roberts, J.J.2
-
18
-
-
0016945130
-
Effects of cis-dichlorodiammineplatinum (II) on DNA synthesis in kidney and other tissues of normal and tumor-bearing rats
-
18. Taylor, D. M., Tew, K. D., and Jones, J. D. Effects of cis-dichlorodiammineplatinum (II) on DNA synthesis in kidney and other tissues of normal and tumor-bearing rats, Eur. J. Cancer 12, 249-254 (1976).
-
(1976)
Eur. J. Cancer
, vol.12
, pp. 249-254
-
-
Taylor, D.M.1
Tew, K.D.2
Jones, J.D.3
-
19
-
-
0023720156
-
Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney kortex: Different effect of antioxidants and radical scavengers
-
19. Hannemann, J., and Baumann, K. Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney kortex: Different effect of antioxidants and radical scavengers, Toxicology 51, 119-132.
-
Toxicology
, vol.51
, pp. 119-132
-
-
Hannemann, J.1
Baumann, K.2
-
20
-
-
0027965261
-
Cisplatin generates superoxide anion by intercalation with DNA in a cell free system
-
20. Masuda, H., Tanaka, T., and Takahama, U. Cisplatin generates superoxide anion by intercalation with DNA in a cell free system, Biochem. Biophys. Res. Commun. 203, 1175-1180 (1994).
-
(1994)
Biochem. Biophys. Res. Commun.
, vol.203
, pp. 1175-1180
-
-
Masuda, H.1
Tanaka, T.2
Takahama, U.3
-
21
-
-
0028905096
-
Free radicals dependent and independent pathways of CDDP-mediated cytotoxicity and apoptosis in ovarian tumor cell lines
-
21. Uslu, R., and Bonavida, B. Free radicals dependent and independent pathways of CDDP-mediated cytotoxicity and apoptosis in ovarian tumor cell lines, Int. J. Oncol. 6, 1003-1009 (1995).
-
(1995)
Int. J. Oncol.
, vol.6
, pp. 1003-1009
-
-
Uslu, R.1
Bonavida, B.2
-
22
-
-
0018956422
-
Enhancement of naturally occurring human spontaneous monocyte-mediated cytotoxicity by cis-diamminedichloroplatinum (II)
-
22. Kleinerman, E. S., Zwelling, L. A., and Mushmore, A. V. Enhancement of naturally occurring human spontaneous monocyte-mediated cytotoxicity by cis-diamminedichloroplatinum (II), Cancer Res. 40, 3099-3102 (1980).
-
(1980)
Cancer Res.
, vol.40
, pp. 3099-3102
-
-
Kleinerman, E.S.1
Zwelling, L.A.2
Mushmore, A.V.3
-
23
-
-
0022640565
-
Enhancement of natural killer cytotoxicity by cis-diamminedichloroplatinum (II) in vivo and in vitro
-
23. Lichenstein, A. K., and Pende, D. Enhancement of natural killer cytotoxicity by cis-diamminedichloroplatinum (II) in vivo and in vitro, Cancer Res. 46, 639-644 (1985).
-
(1985)
Cancer Res.
, vol.46
, pp. 639-644
-
-
Lichenstein, A.K.1
Pende, D.2
-
24
-
-
0025572458
-
Activation of human natural killer cells and monocytes with cisplatin in vitro
-
24. Sohdi, A., Pai, K., Singh, R. K., and Singh, S. M. Activation of human natural killer cells and monocytes with cisplatin in vitro, Int. J. Immunopharmacol. 12, 893-898 (1990).
-
(1990)
Int. J. Immunopharmacol.
, vol.12
, pp. 893-898
-
-
Sohdi, A.1
Pai, K.2
Singh, R.K.3
Singh, S.M.4
-
25
-
-
0027446372
-
Enhanced susceptibility of CDDP-treateated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells
-
25. Mizutani, Y., Bonavida, B., Nio, Y., and Yoshida, O. Enhanced susceptibility of CDDP-treateated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells, Cancer 71, 1313-1321.
-
Cancer
, vol.71
, pp. 1313-1321
-
-
Mizutani, Y.1
Bonavida, B.2
Nio, Y.3
Yoshida, O.4
-
26
-
-
0026714608
-
Activation of human peripheral blood monocytes by CDDP: Enhanced tumoricidal activity and secretion of TNF-α
-
26. Gan, X. H., Jewett, A., and Bonavida, B. Activation of human peripheral blood monocytes by CDDP: Enhanced tumoricidal activity and secretion of TNF-α, Nat. Immun. 11, 144-155 (1992).
-
(1992)
Nat. Immun.
, vol.11
, pp. 144-155
-
-
Gan, X.H.1
Jewett, A.2
Bonavida, B.3
-
27
-
-
0028671833
-
Fas and Fas ligand: A death factor and its receptor
-
27. Nagata, S. Fas and Fas ligand: A death factor and its receptor. Adv. Immunol. 57, 129-144 (1994).
-
(1994)
Adv. Immunol.
, vol.57
, pp. 129-144
-
-
Nagata, S.1
-
28
-
-
0024347970
-
Monoclonal antibody-mediated tumor regression by induction of apoptosis
-
28. Trauth, B. C., Klas, C., Peters, A. M. J., Matzky, S., Moller, P., Falk, W., Debatin, K. M., and Krammer, P. H. Monoclonal antibody-mediated tumor regression by induction of apoptosis, Science 245, 301-304 (1989).
-
(1989)
Science
, vol.245
, pp. 301-304
-
-
Trauth, B.C.1
Klas, C.2
Peters, A.M.J.3
Matzky, S.4
Moller, P.5
Falk, W.6
Debatin, K.M.7
Krammer, P.H.8
-
29
-
-
0024596722
-
A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor
-
29. Yonehara, S., Ishii, A., and Yonehara, M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor, J. Exp. Med. 169, 1747-1756 (1989).
-
(1989)
J. Exp. Med.
, vol.169
, pp. 1747-1756
-
-
Yonehara, S.1
Ishii, A.2
Yonehara, M.3
-
30
-
-
0027291205
-
Lethal effect of anti-Fas antibody in mice
-
30. Ogasawara, J., Watanabe-Fukanaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., and Nagata, S. Lethal effect of anti-Fas antibody in mice, Nature 364, 806-809 (1993).
-
(1993)
Nature
, vol.364
, pp. 806-809
-
-
Ogasawara, J.1
Watanabe-Fukanaga, R.2
Adachi, M.3
Matsuzawa, A.4
Kasugai, T.5
Kitamura, Y.6
Itoh, N.7
Suda, T.8
Nagata, S.9
-
31
-
-
0011841186
-
Apoptosis in APO-1 system
-
(L. D. Tomei and F. O. Cope, Eds.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
-
31. Krammer, P. H., Behrmann, I., Bier, V., Daniel, P., Dhein, J., Falk, M. H., Garcin, G., Klas, C., Knipping, E., Lucking-Famira, K. M., Matzku, S., Oehm, A., Richards, S., Trauth, B. C., Bornkamm, G. W., Falk, W., Moller, P., and Debatin, K. M. Apoptosis in APO-1 system, in Apoptosis: The molecular basis of cell death (L. D. Tomei and F. O. Cope, Eds.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 87-99 (1991).
-
(1991)
Apoptosis: The Molecular Basis of Cell Death
, pp. 87-99
-
-
Krammer, P.H.1
Behrmann, I.2
Bier, V.3
Daniel, P.4
Dhein, J.5
Falk, M.H.6
Garcin, G.7
Klas, C.8
Knipping, E.9
Lucking-Famira, K.M.10
Matzku, S.11
Oehm, A.12
Richards, S.13
Trauth, B.C.14
Bornkamm, G.W.15
Falk, W.16
Moller, P.17
Debatin, K.M.18
-
32
-
-
0026568919
-
Lymphoproliferation disorder in mice explained by defects in fas antigen that mediates apoptosis
-
32. Watanabe-Fukanaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., and Nagata, S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis, Nature (London) 356, 314-317 (1992).
-
(1992)
Nature (London)
, vol.356
, pp. 314-317
-
-
Watanabe-Fukanaga, R.1
Brannan, C.I.2
Copeland, N.G.3
Jenkins, N.A.4
Nagata, S.5
-
33
-
-
0027145632
-
Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
-
33. Suda, T., Takahashi, T., Golstein, P., and Nagata, S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family, Cell 75, 1169-1178 (1993).
-
(1993)
Cell
, vol.75
, pp. 1169-1178
-
-
Suda, T.1
Takahashi, T.2
Golstein, P.3
Nagata, S.4
-
35
-
-
0028110928
-
Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity
-
35. Kagi, D., Vignaux, F., Ledermann, B., Burki, K., Depraetere, V., Nagata, S., Hengartner, H., and Golstein, P. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity, Science 265, 528-530 (1994).
-
(1994)
Science
, vol.265
, pp. 528-530
-
-
Kagi, D.1
Vignaux, F.2
Ledermann, B.3
Burki, K.4
Depraetere, V.5
Nagata, S.6
Hengartner, H.7
Golstein, P.8
-
36
-
-
0028360966
-
Fas and its ligand in a general mechanism of T cell-mediated cytotoxicity
-
36. Hanabuchi, S., Koyanagi, M., Kawasaki, A., Shinohara, N., Matsuzawa, A., Nishimura, Y., Kobayashi, Y., Yonehara, S., Yagita, H., and Okumura, K. Fas and its ligand in a general mechanism of T cell-mediated cytotoxicity, Proc. Natl. Acad. USA 91, 4930-4934 (1994).
-
(1994)
Proc. Natl. Acad. USA
, vol.91
, pp. 4930-4934
-
-
Hanabuchi, S.1
Koyanagi, M.2
Kawasaki, A.3
Shinohara, N.4
Matsuzawa, A.5
Nishimura, Y.6
Kobayashi, Y.7
Yonehara, S.8
Yagita, H.9
Okumura, K.10
-
37
-
-
0028962125
-
Fas-mediated cytotoxicity by freshly isolated natural killer cells
-
37. Arase, H., Arasi, N., and Saito, T. Fas-mediated cytotoxicity by freshly isolated natural killer cells, J. Exp. Med. 181, 1235-1238 (1995).
-
(1995)
J. Exp. Med.
, vol.181
, pp. 1235-1238
-
-
Arase, H.1
Arasi, N.2
Saito, T.3
-
38
-
-
0028357173
-
Rapid quantation of apoptosis in pure and heterogenous cell populations using flow cytometry
-
38. Telford, W. G., King, L. E., and Fraker, P. J. Rapid quantation of apoptosis in pure and heterogenous cell populations using flow cytometry, J. Immunol. Methods 172, 1-16 (1994).
-
(1994)
J. Immunol. Methods
, vol.172
, pp. 1-16
-
-
Telford, W.G.1
King, L.E.2
Fraker, P.J.3
-
39
-
-
0026492817
-
Features of apoptotic cells measured by flow cytometry
-
39. Darzynkiewicz, Z., Bruno, S., Del Nino, G., Gorzycca, W., Hotz, M. A., Lassota, P., and Traganos, F. Features of apoptotic cells measured by flow cytometry, Cytometry 13, 795-808 (1992).
-
(1992)
Cytometry
, vol.13
, pp. 795-808
-
-
Darzynkiewicz, Z.1
Bruno, S.2
Del Nino, G.3
Gorzycca, W.4
Hotz, M.A.5
Lassota, P.6
Traganos, F.7
-
40
-
-
0019750732
-
Criterion for analyzing interactions between biologically active agents
-
40. Berenbaum, M. C. Criterion for analyzing interactions between biologically active agents, Adv. Cancer Res. 35, 269-290 (1981).
-
(1981)
Adv. Cancer Res.
, vol.35
, pp. 269-290
-
-
Berenbaum, M.C.1
-
41
-
-
0024428198
-
Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor
-
41. Wong, G. H. W., Elwell, J. H., Oberly, L. W., and Goeddel, D. V. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor, Cell 58, 923-931 (1989).
-
(1989)
Cell
, vol.58
, pp. 923-931
-
-
Wong, G.H.W.1
Elwell, J.H.2
Oberly, L.W.3
Goeddel, D.V.4
-
42
-
-
0028287963
-
Fas and tumor necrosis factor receptor-mediated cell death: Similarities and distinctions
-
42. Clement, M. V., and Stamenkovic, I. Fas and tumor necrosis factor receptor-mediated cell death: Similarities and distinctions, J. Exp. Med. 180, 557-567 (1994).
-
(1994)
J. Exp. Med.
, vol.180
, pp. 557-567
-
-
Clement, M.V.1
Stamenkovic, I.2
-
43
-
-
0027994239
-
Cell nucleus and DNA fragmentation are not required for apoptosis
-
43. Schulze-Osthoff, K., Walczak, H., Droge, W., and Krammer, P. H. Cell nucleus and DNA fragmentation are not required for apoptosis, J. Cell Biol. 127, 15-20 (1994).
-
(1994)
J. Cell Biol.
, vol.127
, pp. 15-20
-
-
Schulze-Osthoff, K.1
Walczak, H.2
Droge, W.3
Krammer, P.H.4
|